Table 3 Univariate analysis of prediction for FTR following highly advanced HBPS
n | OR | 95%CI | p-value | |
|---|---|---|---|---|
Age (years) | ||||
>75 | 56 | 2.86 | 0.73-12.00 | 0.13 |
<75 | 121 | 1 | ||
Sex | ||||
Male | 121 | 1.66 | 0.39-11.37 | 0.52 |
Female | 56 | 1 | ||
BMI (kg/m2) | ||||
>24 | 46 | 0.34 | 0.02-1.94 | 0.26 |
<24 | 131 | 1 | ||
ASA | ||||
3 | 20 | 4.44 | 0.88-18.53 | 0.07 |
1/2 | 157 | 1 | ||
Smoking | ||||
Yes | 99 | 4.18 | 0.72-79.29 | 0.12 |
No | 78 | 1 | ||
Past abdominal surgery | ||||
Yes | 76 | 0.65 | 0.13-2.55 | 0.55 |
No | 101 | 1 | ||
Preoperative-chemotherapy | ||||
Yes | 33 | 0.53 | 0.03-3.05 | 0.53 |
No | 144 | 1 | ||
PNIa | ||||
>40 | 100 | 0.35 | 0.05-1.52 | 0.17 |
<40 | 77 | 1 | ||
Modified GPS | ||||
1/2 | 49 | 0.74 | 0.11-3.17 | 0.70 |
0 | 128 | 1 | ||
SIIb | ||||
>437 | 88 | 1.26 | 0.32-5.27 | 0.73 |
<437 | 89 | 1 | ||
Charlson risk index | ||||
2+ | 93 | 1.14 | 0.29-4.73 | 0.85 |
0/1 | 84 | 1 | ||
History of malignancy | ||||
Yes | 56 | 1.08 | 0.22-4.28 | 0.91 |
No | 121 | 1 | ||
Heart-related comorbidity | ||||
Yes | 30 | 1.43 | 0.21-6.29 | 0.68 |
No | 147 | 1 | ||
Respiratory-related comorbidity | ||||
Yes | 31 | 1.36 | 0.20-6.02 | 0.71 |
No | 146 | 1 | ||
Liver-related comorbidity | ||||
Yes | 29 | 4.58 | 1.07-18.46 | 0.04* |
No | 148 | 1 | ||
Cerebrovascular-related comorbidity | ||||
Yes | 15 | 0.00 | -2.59 | 0.2 |
No | 162 | 1 | ||
Diabetes mellitus | ||||
Yes | 58 | 1.03 | 0.21-4.05 | 0.97 |
No | 119 | 1 | ||
Chronic renal dysfunction | ||||
Yes | 12 | 1.78 | 0.09-11.09 | 0.62 |
No | 165 | 1 | ||
Type of surgery | ||||
Hepatobiliary | 69 | 2.03 | 0.52-8.47 | 0.30 |
Pancreas | 108 | 1 | ||
Operative time (min) | ||||
>420 | 88 | 1.28 | 0.33-5.33 | 0.72 |
<420 | 89 | 1 | ||
Blood loss (ml) | ||||
>1600 | 25 | 71.06 | 12.02-1359.77 | <0.001*** |
<1600 | 152 | 1 | ||
Blood transfusion | ||||
Yes | 48 | 10.84 | 2.51-74.70 | <0.01** |
No | 129 | 1 | ||
Onset time of complication (POD) | ||||
>12 | 32 | 3.97 | 0.93-15.93 | 0.06 |
<12 | 145 | 1 | ||
Pancreatic fistula | ||||
Yes | 76 | 0.36 | 0.05-1.55 | 0.18 |
No | 101 | 1 | ||
Bile leakage | ||||
Yes | 25 | 0.00 | -0.00 | 0.09 |
No | 152 | 1 | ||
Liver failure | ||||
Yes | 6 | 66.4 | 10.6-574.22 | <0.001*** |
No | 171 | 1 | ||
Respiratory failure | ||||
Yes | 10 | 82 | 16.28-530.28 | <0.001*** |
No | 167 | 1 | ||
Postoperative bleeding | ||||
Yes | 25 | 5.6 | 1.30-22.84 | 0.02* |
No | 152 | 1 | ||
Re-operation | ||||
Yes | 12 | 1.78 | 0.09-11.09 | 0.62 |
No | 165 | 1 | ||
White blood cell on POD3 (×103µl) | ||||
>10000 | 73 | 1.84 | 0.47-7.66 | 0.38 |
<10000 | 104 | 1 | ||
C-reactive protein on POD3 (mg/dl) | ||||
>15 | 93 | 0.69 | 0.17-2.71 | 0.59 |
<15 | 84 | 1 | ||
Albumin (g/dl) | ||||
>2.8 | 70 | 1.24 | 0.20-4.85 | 0.76 |
<2.8 | 107 | 1 | ||